X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (130) 130
pharmacotherapy (130) 130
humans (118) 118
pharmacology & pharmacy (109) 109
medicine & public health (103) 103
pharmacology/toxicology (88) 88
internal medicine (84) 84
toxicology (74) 74
drug therapy (42) 42
care and treatment (41) 41
dosage and administration (40) 40
clinical trials (38) 38
research (34) 34
usage (29) 29
treatment outcome (28) 28
drug dosages (27) 27
patients (27) 27
pharmacokinetics (25) 25
safety (25) 25
adult (24) 24
female (24) 24
health aspects (23) 23
adults (22) 22
animals (20) 20
double-blind (20) 20
efficacy (20) 20
pharmacy (19) 19
drug therapy, combination (18) 18
male (18) 18
tolerability (17) 17
management (16) 16
randomized controlled trials as topic (16) 16
drug combinations (15) 15
risk factors (15) 15
studies (15) 15
clinical trials as topic (14) 14
infections (13) 13
oncology (13) 13
psychiatry (13) 13
quality of life (13) 13
adis-drug-profiles (12) 12
drug approval (12) 12
hiv infections - drug therapy (12) 12
immunology (12) 12
prevention (12) 12
abridged index medicus (11) 11
antineoplastic agents - therapeutic use (11) 11
biomedicine (11) 11
cancer research (11) 11
molecular medicine (11) 11
mutation (11) 11
neurosciences (11) 11
pharmacodynamics (11) 11
therapeutic use (11) 11
analysis (10) 10
antibodies (10) 10
child (10) 10
clinical neurology (10) 10
clinical trials, phase iii as topic (10) 10
drug interactions (10) 10
hiv infection (10) 10
neurology (10) 10
pediatrics (10) 10
psychopharmacology (10) 10
therapy (10) 10
adolescent (9) 9
children (9) 9
dose-response relationship, drug (9) 9
hiv-1 - drug effects (9) 9
in-vitro (9) 9
middle aged (9) 9
patient outcomes (9) 9
aged (8) 8
antiretroviral therapy (8) 8
arthritis (8) 8
complications and side effects (8) 8
human immunodeficiency virus--hiv (8) 8
pharmacology (8) 8
tenofovir (8) 8
adis drug profiles (7) 7
adolescents (7) 7
antibodies, monoclonal, humanized - adverse effects (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
antineoplastic agents - pharmacology (7) 7
cancer (7) 7
combination (7) 7
diabetes (7) 7
diagnosis (7) 7
emtricitabine (7) 7
immunogenicity (7) 7
rheumatoid arthritis (7) 7
risk (7) 7
tablets (7) 7
acquired immune deficiency syndrome--aids (6) 6
adis-drug-evaluations (6) 6
administration, oral (6) 6
anti-hiv agents - therapeutic use (6) 6
antibodies, monoclonal - therapeutic use (6) 6
antineoplastic agents - adverse effects (6) 6
antirheumatic agents - therapeutic use (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 5/2019, Volume 79, Issue 7, pp. 795 - 795
The article Sarecycline: First Global Approval, written by Emma D. Deeks, was originally published Online First without open access. After publication in... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology
Journal Article
Drugs, ISSN 0012-6667, 03/2019, Volume 79, Issue 6, pp. 687 - 687
The article Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection, written by Emma D. Deeks, was originally published Online First... 
Journal Article
Drugs, ISSN 0012-6667, 2/2019, Volume 79, Issue 3, pp. 325 - 329
Journal Article
Drugs, ISSN 0012-6667, 3/2019, Volume 79, Issue 4, pp. 469 - 469
Journal Article
Drugs, ISSN 0012-6667, 11/2018, Volume 78, Issue 17, pp. 1817 - 1828
Journal Article
Drugs, ISSN 0012-6667, 3/2019, Volume 79, Issue 4, pp. 463 - 468
Journal Article
Drugs, ISSN 0012-6667, 07/2018, Volume 78, Issue 10, pp. 1013 - 1024
Darunavir/cobicistat/emtricitabine/tenofovir AF (Symtuza®) is the first protease inhibitor (PI)-based single-tablet regimen (STR) available for the treatment... 
Emtricitabine | Short tandem repeats | Adolescence | Antiretroviral drugs | RNA-directed DNA polymerase | Clinical trials | Lipids | Proteinase inhibitors | Infections | Pharmacology | Drug resistance | Patients | Antiretroviral therapy | Tenofovir | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Adults | Mutation | Bone | Adolescents
Journal Article
CNS Drugs, ISSN 1172-7047, 2/2019, Volume 33, Issue 2, pp. 193 - 193
The article Cladribine Tablets: A Review in Relapsing MS, written by Emma D. Deeks, was originally published Online First without open access. 
Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology
Journal Article
Drugs, ISSN 0012-6667, 9/2019, Volume 79, Issue 13, pp. 1495 - 1495
The article Damoctocog Alfa Pegol: A Review in Haemophilia A, written by Julia Paik and Emma D. Deeks, was originally published Online First without open... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Index Medicus
Journal Article
Drugs, ISSN 0012-6667, 4/2019, Volume 79, Issue 5, pp. 589 - 589
The article Tapentadol Prolonged Release: A Review in Pain Management, written by Emma D. Deeks, was originally published Online First without open access. 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology
Journal Article
Journal Article
Drugs & Aging, ISSN 1170-229X, 3/2018, Volume 35, Issue 3, pp. 261 - 261
In the original publication the name of the fourth reviewer was incorrectly published. 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology
Journal Article
BioDrugs, ISSN 1173-8804, 10/2018, Volume 32, Issue 5, pp. 525 - 525
The article GP2015: An Etanercept Biosimilar, written by Emma D. Deeks, was originally published Online First without open access. After publication in volume... 
Antibodies | Pharmacotherapy | Cancer Research | Molecular Medicine | Biomedicine
Journal Article
Drugs, ISSN 0012-6667, 01/2013, Volume 73, Issue 1, p. 75
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 04/2019, Volume 39, Issue 4, pp. 411 - 418
The sufentanil 30 μg sublingual tablet (hereafter referred to as the sufentanil ST) is approved in the EU for acute moderate to severe pain in adults (Dzuveo™)... 
Medicine | Metabolites | Analgesics | Narcotics | Surgery | Pain management | Emergency medical care | Anesthesiology | Bioavailability | Trauma | Drug dosages
Journal Article
Drugs and Aging, ISSN 1170-229X, 03/2018, Volume 35, Issue 3, p. 261
Journal Article
Targeted Oncology, ISSN 1776-2596, 2/2019, Volume 14, Issue 1, pp. 107 - 113
Cabozantinib is an inhibitor of multiple receptor tyrosine kinases (RTKs) with roles in cancer pathogenesis. This review focuses on data relevant to the use of... 
Biomedicine, general | Medicine & Public Health | Oncology | VEGFR2 | METASTASIS | PHARMACOKINETICS | ONCOLOGY | GROWTH | INHIBITOR | SYSTEMIC THERAPY | MET | Tyrosine | Hepatoma | Liver cancer | Inhibitor drugs | Pathogenesis | Targeted cancer therapy
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 12/2016, Volume 17, Issue 6, pp. 701 - 707
Deoxycholic acid is a secondary bile acid involved in dietary fat emulsification/solubilization that causes adipocyte lysis when injected into subcutaneous fat... 
Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | ATX-101 | REDUCTION | PHASE-III | DERMATOLOGY | Dietary fat | Research | Deoxycholic acid
Journal Article
Drugs & Therapy Perspectives, ISSN 1172-0360, 2/2019, Volume 35, Issue 2, pp. 51 - 57
The Bydureon® BCise® pre-filled pen was developed largely to simplify self-administration of exenatide extended-release for patients with type 2 diabetes,... 
Pharmacotherapy | Pharmacy | Diabetes | Patient satisfaction | Hypoglycemia | Drug dosages
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.